Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.
复制标题
DOI:
10.1002/sim.5757
复制
发表时间:
2013-07-30
影响因子:
2
通讯作者:
Stallard, Nigel
中科院分区:
文献类型:
--
作者:
Kimani, Peter K.;Todd, Susan;Stallard, Nigel
Seamless phase II/III clinical trials combine traditional phases II and III into a single trial that is conducted in two stages, with stage 1 used to answer phase II objectives such as treatment selection and stage 2 used for the confirmatory analysis, which is a phase III objective. Although seamless phase II/III clinical trials are efficient because the confirmatory analysis includes phase II data from stage 1, inference can pose statistical challenges. In this paper, we consider point estimation following seamless phase II/III clinical trials in which stage 1 is used to select the most effective experimental treatment and to decide if, compared with a control, the trial should stop at stage 1 for futility. If the trial is not stopped, then the phase III confirmatory part of the trial involves evaluation of the selected most effective experimental treatment and the control. We have developed two new estimators for the treatment difference between these two treatments with the aim of reducing bias conditional on the treatment selection made and on the fact that the trial continues to stage 2. We have demonstrated the properties of these estimators using simulations. Copyright © 2013 John Wiley & Sons, Ltd.
登录
查看更多内容
影响因子:
2
作者:
Koenig, Franz;Brannath, Werner;Posch, Martin
通讯作者:
Posch, Martin
影响因子:
2.7
作者:
WHITEHEAD, J
通讯作者:
WHITEHEAD, J
影响因子:
2
作者:
Koopmeiners, Joseph S.;Feng, Ziding;Pepe, Margaret Sullivan
通讯作者:
Pepe, Margaret Sullivan
影响因子:
2
作者:
Kimani, Peter K.;Stallard, Nigel;Hutton, Jane L.
通讯作者:
Hutton, Jane L.
影响因子:
1.7
作者:
Bowden, Jack;Glimm, Ekkehard
通讯作者:
Glimm, Ekkehard